Dosage and administration
Feel the emotion fully, breathe deeply-connected breaths. Put 5 drops under tongue to release emotion. Continue 5 drops 2 times daily as needed. Consult a physician for use in children under 12 years of age.
Feel the emotion fully, breathe deeply-connected breaths. Put 5 drops under tongue to release emotion. Continue 5 drops 2 times daily as needed. Consult a physician for use in children under 12 years of age.
Oxytocin 6X, 12X, 30X, Chimaphila Umbellata 3C, Pituitary (Suis) 3C, Uva Ursi 5C, Orchitinum (Suis) 5C, 8C, Prostate (Suis) 8C, Sarsaparilla 8C, 55C, Gelsemium Sempervirens 34C, Zincum Metallicum 55C, Kali Phosphoricum 144C, Phosphoricum Acidum 233C.
For temporary relief of emotionlessness, denial, numbness, and unresponsiveness.
If pregnant or breast-feeing, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Do not use if seal is broken or missing.
Feel the emotion fully, breathe deeply-connected breaths. Put 5 drops under tongue to release emotion. Continue 5 drops 2 times daily as needed. Consult a physician for use in children under 12 years of age.
Demineralized Water, 25% Ethanol
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
For temporary relief of emotionlessness, denial, numbness, and unresponsiveness.
MFD. FOR:
The Wellness Center for Research
and Education, Inc.
1237 S. Victoria Ave. Suite 169
Oxnard, CA 93035
Dr. Theresa Dale's
MIND~BODY~MERIDIAN
NDC: 50181-0019-1
Fibonacci Series
12
Male
Unresponsive
HOMEOPATHIC
1 fluid oz. (30 ml)
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 50181-0019-1 | 2025-05-30 | C162847 | 48780-1 | 9d75b9d0-c8a4-f424-e053-dadaa90a57ce | Drug Facts: |
| 50181-0019-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-c8a4-f424-e053-dadaa90a57ce | Drug Facts: |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ARCTOSTAPHYLOS UVA-URSI LEAF | ACTIVE INGREDIENT | 3M5V3D1X36 | 2 | |
| CHIMAPHILA UMBELLATA | ACTIVE INGREDIENT | WCK21A9W9J | 2 | |
| GELSEMIUM SEMPERVIRENS ROOT | ACTIVE INGREDIENT | 639KR60Q1Q | 2 | |
| OXYTOCIN | ACTIVE INGREDIENT | 1JQS135EYN | 2 | |
| PHOSPHORIC ACID | ACTIVE INGREDIENT | E4GA8884NN | 2 | |
| POTASSIUM PHOSPHATE, DIBASIC | ACTIVE INGREDIENT | CI71S98N1Z | 2 | |
| SARSAPARILLA | ACTIVE INGREDIENT | 2H1576D5WG | 2 | |
| SUS SCROFA PITUITARY GLAND | ACTIVE INGREDIENT | E8S87O660T | 2 | |
| SUS SCROFA PROSTATE | ACTIVE INGREDIENT | O6UD3347K2 | 2 | |
| SUS SCROFA TESTICLE | ACTIVE INGREDIENT | KM02613O28 | 2 | |
| ZINC | ACTIVE INGREDIENT | J41CSQ7QDS | 2 | |
| ARCTOSTAPHYLOS UVA-URSI LEAF | ACTIVE MOIETY | 3M5V3D1X36 | 2 | |
| CHIMAPHILA UMBELLATA | ACTIVE MOIETY | WCK21A9W9J | 2 | |
| GELSEMIUM SEMPERVIRENS ROOT | ACTIVE MOIETY | 639KR60Q1Q | 2 | |
| OXYTOCIN | ACTIVE MOIETY | 1JQS135EYN | 2 | |
| PHOSPHATE ION | ACTIVE MOIETY | NK08V8K8HR | 2 | |
| PHOSPHORIC ACID | ACTIVE MOIETY | E4GA8884NN | 2 | |
| SARSAPARILLA | ACTIVE MOIETY | 2H1576D5WG | 2 | |
| SUS SCROFA PITUITARY GLAND | ACTIVE MOIETY | E8S87O660T | 2 | |
| SUS SCROFA PROSTATE | ACTIVE MOIETY | O6UD3347K2 | 2 | |
| SUS SCROFA TESTICLE | ACTIVE MOIETY | KM02613O28 | 2 | |
| ZINC | ACTIVE MOIETY | J41CSQ7QDS | 2 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 50181-0019 | 50181-0019-1 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| OXYTOCIN | 1JQS135EYN | ACTIB |
| CHIMAPHILA UMBELLATA | WCK21A9W9J | ACTIB |
| SUS SCROFA PITUITARY GLAND, POSTERIOR | E8S87O660T | ACTIB |
| ARCTOSTAPHYLOS UVA-URSI LEAF | 3M5V3D1X36 | ACTIB |
| SUS SCROFA TESTICLE | KM02613O28 | ACTIB |
| SUS SCROFA PROSTATE | O6UD3347K2 | ACTIB |
| SARSAPARILLA | 2H1576D5WG | ACTIB |
| GELSEMIUM SEMPERVIRENS ROOT | 639KR60Q1Q | ACTIB |
| ZINC | J41CSQ7QDS | ACTIB |
| POTASSIUM PHOSPHATE, DIBASIC | CI71S98N1Z | ACTIB |
| PHOSPHORIC ACID | E4GA8884NN | ACTIB |
| WATER | 059QF0KO0R | IACT |
| ALCOHOL | 3K9958V90M | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ALCOHOL | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TOPICAL | 9971 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LOTION / TOPICAL | 25 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | MOUTHWASH / BUCCAL | 200 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 35.75 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAVENOUS | 6405 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, EMULSION / INTRAVENOUS | 520 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVASCULAR | 100 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TRANSDERMAL | 3675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / NASAL | 20 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / NASAL | 10 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / RESPIRATORY (INHALATION) | 0.08 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAMUSCULAR | 1491 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVESICAL | 7892 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVENOUS | 92 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / TOPICAL | 561 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / NASAL | 10 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / RECTAL | 898 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | PASTE / DENTAL | 1.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TOPICAL | 3633 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / INTRAVENOUS | 4000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAVENOUS | 400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | JELLY / VAGINAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | POWDER, FOR SOLUTION / TOPICAL | 40 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / BUCCAL | 679 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / RESPIRATORY (INHALATION) | 26664 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| af3ad27a-2e69-44d7-8cc3-440223e2a5eb | 4cdbf233-28db-4697-9787-85366ff19bc6 | 2025-05-30 | Warnings | af3ad27a-2e69-44d7-8cc3-440223e2a5eb 4cdbf233-28db-4697-9787-85366ff19bc6 |
Adverse event summaries are temporarily unavailable. Other product information remains available.